SKB571 for injection

DRUG4 trials

Sponsors

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Conditions

Gastrointestinal TumorsLung Cancer (Non-Small Cell)Non-Small Cell Lung CancerNon-small Lung Cancer

Phase 2

A Phase II Study of SKB571 in Patients With Lung Cancer

RecruitingNCT07230405

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Lung Cancer (Non-Small Cell)

Start: 2026-01-19End: 2028-01-19Target: 295Updated: 2026-05-12

A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities

RecruitingNCT07308106

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Non-small Lung Cancer

Start: 2026-04-03End: 2029-03-31Target: 70Updated: 2026-07-30

A Study of SKB571 in Participants With Gastrointestinal Tumors

RecruitingNCT07564466

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Gastrointestinal Tumors

Start: 2026-05-20End: 2028-06-30Target: 120Updated: 2026-08-04

A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)

RecruitingNCT07622186

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Non-Small Cell Lung Cancer

Start: 2026-07-15End: 2029-12-31Target: 150Updated: 2026-09-02